Abstract:The intestinal mucosa is constantly exposed to commensal microbes, opportunistic pathogens, toxins, luminal components and other environmental stimuli. The intestinal mucosa consists of multiple differentiated cellular and extracellular components that form a critical barrier, but is also equipped for efficient absorption of nutrients. Combination of genetic susceptibility and environmental factors are known as critical components involved in the pathogenesis of intestinal diseases. The innate immune system plays a critical role in the recognition and elimination of potential threats by detecting pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs). This host defense is facilitated by pattern recognition receptors (PRRs), in which the cyclic GMP-AMP synthase-stimulator of interferon genes (cGAS-STING) pathway has gained attention due to its role in sensing host and foreign double-stranded DNA (dsDNA) as well as cyclic dinucleotides (CDNs) produced by bacteria. Upon binding with dsDNA, cGAS converts ATP and GTP to cyclic GMP-AMP (cGAMP), which binds to STING and activates TANK binding kinase 1 (TBK1) and interferon regulatory factor 3 (IRF3), inducing type I interferon (IFN) and nuclear factor kappa B (NF-κB)-mediated pro-inflammatory cytokines, which have diverse effects on innate and adaptive immune cells and intestinal epithelial cells (IECs). However, opposite perspectives exist regarding the role of the cGAS-STING pathway in different intestinal diseases. Activation of cGAS-STING signaling is associated with worse clinical outcomes in inflammation-associated diseases, while it also plays a critical role in protection against tumorigenesis and certain infections. Therefore, understanding the context-dependent mechanisms of the cGAS-STING pathway in the physiopathology of the intestinal mucosa is crucial for developing therapeutic strategies targeting the cGAS-STING pathway. This review aims to provide insight into recent findings of the protective and detrimental roles of the cGAS-STING pathway in intestinal diseases.

cGAS-cGAMP-STING recognizes DNA in inflammatory bowel disease

Microbial DNA Recognition by Cgas-Sting and Other Sensors in Dendritic Cells in Inflammatory Bowel Diseases.

cGAS-STING signaling pathway in gastrointestinal inflammatory disease and cancers

Lysosomal Control of the Cgas-Sting Signaling.

Cellular functions of cGAS-STING signaling

cGAS-STING signaling pathway in intestinal homeostasis and diseases

cGAS in action: Expanding roles in immunity and inflammation

cGAS-cGAMP-STING: The three musketeers of cytosolic DNA sensing and signaling.

The role of cGAS in epithelial dysregulation in inflammatory bowel disease and gastrointestinal malignancies

Stimulator of Interferon Genes in Classical Dendritic Cells Controls Mucosal Th17 Responses to Cyclic Dinucleotides for Host Defenses Against Microbial Infections in Gut.

The triggers of the cGAS-STING pathway and the connection with inflammatory and autoimmune diseases

The cGAS–cGAMP–STING pathway connects DNA damage to inflammation, senescence, and cancer

Chemical regulation of the cGAS-STING pathway

Cell-to-cell communications of cGAS-STING pathway in tumor immune microenvironment.

Cytosolic sensor STING in mucosal immunity: a master regulator of gut inflammation and carcinogenesis

Significance of the cGAS-STING Pathway in Health and Disease

The cGAS-STING pathway: The role of self-DNA sensing in inflammatory lung disease

Updated roles of cGAS-STING signaling in autoimmune diseases

Current understanding of the cGAS-STING signaling pathway: Structure, regulatory mechanisms, and related diseases

Cytosolic DNA sensing by cGAS: regulation, function, and human diseases

New Frontiers on Intracellular cGAS Activation: Molecular Mechanisms, Cellular Signaling, and Therapeutic Strategies